Program
The Program is still in development - please check back for updates and more details.
-
Innovative trial designs in practice: turning lessons learned into efficiencies gained for children with neurodevelopmental disabilities
Tuesday, October 27 10:15 AM - 11:15 AM
-
What does co-design mean to you? Thinking through mechanisms for clinical trial co-design through a youth perspective
Tuesday, October 27 11:15 AM - 12:00 PM
-
IMPaCT Elevator Pitch Competition
Tuesday, October 27 2:00 PM - 3:00 PM
Early career researchers, PhD students, and postdoctoral fellows compete in a fast-paced showcase of maternal and child health research in front of IMPaCT fellows, mentors, and research leaders. About the competition: Fellows have just three minutes to present their clinical trial concept with clarity, precision, and impact. No slides. No props. Just their voice and vision. This is where emerging talent meets seasoned expertise and where the next generation of clinical trial leaders takes the stage.
-
-
IMPaCT Networking Night
Tuesday, October 27 3:30 PM - 9:30 PM
The evening will begin with an outdoor Escape Room experience in Old Montréal, followed by a group dinner at Pub Saint‑Paul. More details and logistics will be shared closer to the event.
Pre-registration required.
-
Beyond good intentions, reducing red tape to facilitate inclusion of pregnant and lactating people in clinical trials
Wednesday, October 28 8:45 AM - 9:45 AM
This session features a panel of diverse perspectives and centered on describing the broad framework for creating and running clinical trials for pregnant populations.
-
From Ideas to Action: Planning Clinical Trials in Pregnancy
Wednesday, October 28 10:30 AM - 12:00 PM
This session will focus on practical suggestions and applications, including what we can change in our individual trials, as communities and what we want to advocate for in future system level change.
-
Decentralized Clinical Trials Panel
Wednesday, October 28 2:15 PM - 4:30 PM
This panel brings together investigators, regulators, industry leaders, and health system partners to explore practical implementation of decentralized trial approaches, including remote monitoring, hybrid site models, digital consent, and patient-centered logistics. The discussion will focus on operational realities, regulatory considerations, and lessons learned from real-world application.
Attendees will gain actionable insight into how decentralized models can expand access, reduce burden on families, and improve trial efficiency while maintaining scientific rigor.
-
Group 1: Building the Foundation: Perspectives on ATMP Infrastructure, Skills, and Readiness
Thursday, October 29 8:45 AM - 10:15 AM
A deep dive into the infrastructure, workforce development, and operational readiness required to advance ATMPs in pediatric rare disease clinical trials.
-
Group 2: Re-Thinking Trial Design for Pediatric Rare Diseases
Thursday, October 29 8:45 AM - 10:15 AM
An exploration of innovative and adaptive trial design approaches that address the unique challenges of conducting clinical trials in pediatric rare disease populations.
-
Group 1: Re-Thinking Trial Design for Pediatric Rare Diseases
Thursday, October 29 10:30 AM - 12:00 PM
An exploration of innovative and adaptive trial design approaches that address the unique challenges of conducting clinical trials in pediatric rare disease populations.
Crossover session — participants switch groups (Group 1 → Group 2; Group 2 → Group 1).
-
Group 2: Building the Foundation: Perspectives on ATMP Infrastructure, Skills, and Readiness
Thursday, October 29 10:30 AM - 12:00 PM
A deep dive into the infrastructure, workforce development, and operational readiness required to advance ATMPs in pediatric rare disease clinical trials.
Crossover session — participants switch groups (Group 1 → Group 2; Group 2 → Group 1).
-
Regulatory Reform & System Innovation Plenary Session
Thursday, October 29 1:00 PM - 2:45 PM
This plenary bring scientific, regulatory, health system, and industry leaders into focused dialogue on the pathways that determine whether innovative therapies reach children in Canada.
Discussion will address evidence requirements, market access dynamics, system readiness, and the reforms needed to strengthen Canada’s competitiveness in rare disease clinical trials.
Event Dates
October 27-29, 2026